|
Histology
|
Serous
|
Mucinous
|
Endometrioid
|
Clear cell
|
Transitional cell
|
Carcinosarcoma
|
|---|
|
SIR
|
CI
|
SIR
|
CI
|
SIR
|
CI
|
SIR
|
CI
|
SIR
|
CI
|
SIR
|
CI
|
|---|
|
Leukaemia
|
4.77#
|
(2.83–7.54)
|
1.14
|
(0.14–4.11)
|
0.00
|
(0.00–3.95)
|
3.48
|
(0.42–12.58)
|
0.00
|
(0.00–37.27)
|
0.00
|
(0.00–127.79)
|
|
Urinary bladder
|
1.81
|
(0.59–4.22)
|
1.68
|
(0.20–6.06)
|
4.59
|
(0.95–13.43)
|
0.00
|
(0.00–11.77)
|
0.00
|
(0.00–51.86)
|
0.00
|
(0.00–128.39)
|
|
Lung, bronchus
|
1.08
|
(0.71–1.58)
|
3.59#
|
(2.52–4.98)
|
1.54
|
(0.70–2.92)
|
2.51#
|
(1.08–4.94)
|
1.52
|
(0.0–8.47)
|
0.00
|
(0.00–15.84)
|
|
Rectum, rectosigmoid junction
|
1.54#
|
(1.03–2.23)
|
1.22
|
(0.56–2.32)
|
1.84
|
(0.79–3.62)
|
0.39
|
(0.01–2.19)
|
2.06
|
(0.05–11.5)
|
0.00
|
(0.00–24.49)
|
|
Thyroid
|
1.27#
|
(1.03–1.55)
|
1.26
|
(0.93–1.68)
|
1.77#
|
(1.24–2.45)
|
1.17
|
(0.70–1.83)
|
2.86#
|
(1.05–6.22)
|
0.00
|
(0.00–9.17)
|
|
Colon
|
1.31
|
(0.99–1.7)
|
1.82#
|
(1.23–2.58)
|
2.56#
|
(1.67–3.75)
|
0.85
|
(0.28–1.98)
|
2.62
|
(0.54–7.65)
|
2.75
|
(0.07–15.33)
|
|
Ascending colon
|
1.01
|
(0.44–1.99)
|
2.93#
|
(1.34–5.57)
|
2.73
|
(0.89–6.37)
|
1.97
|
(0.24–7.11)
|
0.00
|
(0.00–17.3)
|
14.02
|
(0.35–78.11)
|
|
Transverse colon
|
0.62
|
(0.08–2.24)
|
3.97#
|
(1.29–9.27)
|
6.68#
|
(2.17–15.59)
|
4.77
|
(0.58–17.24)
|
0.00
|
(0.00–42.6)
|
0.00
|
(0.00–126.37)
|
|
Descending colon
|
1.01
|
(0.51–1.81)
|
1.41
|
(0.52–3.07)
|
1.94
|
(0.63–4.52)
|
0.00
|
(0.00–2.32)
|
3.40
|
(0.09–18.96)
|
0.00
|
(0.00–42.32)
|
|
Rectum
|
1.59#
|
(1.07–2.29)
|
1.22
|
(0.56–2.32)
|
1.83
|
(0.79–3.61)
|
0.39
|
(0.01–2.18)
|
2.06
|
(0.05–11.47)
|
0.00
|
(0.00–24.43)
|
|
Other and unspecified
|
2.34
|
(0.86–5.09)
|
1.78
|
(0.22–6.45)
|
4.84
|
(1.00–14.14)
|
0.00
|
(0.00–11.74)
|
15.06
|
(0.38–83.91)
|
0.00
|
(0.00–148.5)
|
|
Female breast
|
1.58#
|
(1.26–1.97)
|
0.78
|
(0.47–1.22)
|
1.38
|
(0.83–2.16)
|
0.48
|
(0.16–1.12)
|
1.42
|
(0.17–5.14)
|
3.60
|
(0.09–20.08)
|
|
Kidney parenchyma
|
1.75
|
(0.75–3.44)
|
1.09
|
(0.13–3.95)
|
0.00
|
(0.00–3.35)
|
2.85
|
(0.34–10.29)
|
0.00
|
(0.00–29.83)
|
0.00
|
(0.00–104.36)
|
|
Renal pelvis, other urinary
|
3.37
|
(0.92–8.63)
|
2.15
|
(0.05–11.98)
|
0.00
|
(0.00–13.70)
|
0.00
|
(0.00–27.27)
|
0.00
|
(0.00–117.11)
|
0.00
|
(0.00–310.28)
|
|
Pancreas
|
1.01
|
(0.46–1.92)
|
1.95
|
(0.78–4.02)
|
1.95
|
(0.53–4.98)
|
0.00
|
(0.00–3.49)
|
0.00
|
(0.00–15.72)
|
0.00
|
(0.00–42.09)
|
|
Non-Hodgkin lymphoma
|
1.04
|
(0.42–2.15)
|
1.06
|
(0.22–3.09)
|
0.00
|
(0.00–2.27)
|
0.00
|
(0.00–3.61)
|
0.00
|
(0.00–20.58)
|
19.38
|
(0.49–108.01)
|
|
Bile ducts, other biliary
|
1.37
|
(0.75–2.31)
|
0.72
|
(0.15–2.11)
|
1.69
|
(0.46–4.34)
|
3.45
|
(0.94–8.83)
|
0.00
|
(0.00–13.89)
|
9.79
|
(0.25–54.55)
|
|
Stomach
|
0.88
|
(0.62–1.22)
|
1.14
|
(0.70–1.77)
|
0.91
|
(0.42–1.73)
|
0.36
|
(0.04–1.28)
|
0.00
|
(0.00–3.44)
|
0.00
|
(0.00–10.67)
|
|
Liver
|
0.84
|
(0.42–1.51)
|
0.19
|
(0.00–1.08)
|
0.00
|
(0.00–1.19)
|
1.71
|
(0.35–5.00)
|
0.00
|
(0.00–10.68)
|
9.41
|
(0.24–52.43)
|
|
Gallbladder
|
0.38
|
(0.05–1.38)
|
0.92
|
(0.11–3.33)
|
1.63
|
(0.20–5.87)
|
0.00
|
(0.00–6.08)
|
0.00
|
(0.00–27.04)
|
0.00
|
(0.00–71.35)
|
|
Small intestine
|
2.63
|
(0.54–7.69)
|
2.17
|
(0.05–12.08)
|
0.00
|
(0.00–13.56)
|
0.00
|
(0.00–23.26)
|
0.00
|
(0.00–123.21)
|
0.00
|
(0.00–382.12)
|
|
All excluding POFT
|
1.26#
|
(1.15–1.39)
|
1.26#
|
(1.09–1.45)
|
1.64#
|
(1.38–1.93)
|
0.98
|
(0.74–1.27)
|
1.31
|
(0.68–2.29)
|
2.80#
|
(1.13–5.77)
|
- POFT: peritoneal, epithelial ovarian, and fallopian tubal; SIR: standardised incidence ratio; CI: confidence interval
- #significant at α = 0.05
